Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen C L Torres

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Human Immunology|November 24, 2004
Endogenous IL-4 and IFN-gamma are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cellsKaren C L Torres, Walderez O Dutra, Kenneth J Gollob
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infectionVlaudia M A Costa, Karen C L Torres, Ronaldo Z Mendonça, et al.
Journal of Neuroimmunology|July 20, 2005
Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMCKaren C L Torres, Lis R V Antonelli, Adriano L S Souza, et al.
Infection and Immunity|August 23, 2006
Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasisLis R V Antonelli, Walderez O Dutra, Ricardo R Oliveira, et al.
Archives of Gerontology and Geriatrics|June 16, 2017
Multiple inflammatory markers and 15-year incident ADL disability in admixed older adults: The Bambui-Epigen StudyMaria Fernanda Lima-Costa, Juliana V M Mambrini, Karen C L Torres, et al.
Expert Opinion on Therapeutic Targets|November 21, 2007
Is DARPP-32 a potential therapeutic target?Helton J Reis, Daniela V F Rosa, Melissa M Guimarães, et al.
Journal of Neuroimmunology|May 29, 2016
Immune markers in the RASopathy neurofibromatosis type 1Karen C L Torres, Giselle Lima, Ana C Simões E Silva, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 1, 2022
Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of MortalityBreno S Diniz, Maria Fernanda Lima-Costa, Sérgio Viana Peixoto, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 19, 2017
Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and AdolescentsPriscila M Ferri, Ana C Simões E Silva, Karen C L Torres, et al.
Neurochemical Research|September 4, 2007
DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychoticsBruno R Souza, Bernardo S Motta, Daniela V F Rosa, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Human Immunology|November 24, 2004
Endogenous IL-4 and IFN-gamma are essential for expression of Th2, but not Th1 cytokine message during the early differentiation of human CD4+ T helper cellsKaren C L Torres, Walderez O Dutra, Kenneth J Gollob
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infectionVlaudia M A Costa, Karen C L Torres, Ronaldo Z Mendonça, et al.
Journal of Neuroimmunology|July 20, 2005
Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMCKaren C L Torres, Lis R V Antonelli, Adriano L S Souza, et al.
Infection and Immunity|August 23, 2006
Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasisLis R V Antonelli, Walderez O Dutra, Ricardo R Oliveira, et al.
Archives of Gerontology and Geriatrics|June 16, 2017
Multiple inflammatory markers and 15-year incident ADL disability in admixed older adults: The Bambui-Epigen StudyMaria Fernanda Lima-Costa, Juliana V M Mambrini, Karen C L Torres, et al.
Expert Opinion on Therapeutic Targets|November 21, 2007
Is DARPP-32 a potential therapeutic target?Helton J Reis, Daniela V F Rosa, Melissa M Guimarães, et al.
Journal of Neuroimmunology|May 29, 2016
Immune markers in the RASopathy neurofibromatosis type 1Karen C L Torres, Giselle Lima, Ana C Simões E Silva, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 1, 2022
Cognitive Frailty is Associated With Elevated Proinflammatory Markers and a Higher Risk of MortalityBreno S Diniz, Maria Fernanda Lima-Costa, Sérgio Viana Peixoto, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 19, 2017
Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and AdolescentsPriscila M Ferri, Ana C Simões E Silva, Karen C L Torres, et al.
Neurochemical Research|September 4, 2007
DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychoticsBruno R Souza, Bernardo S Motta, Daniela V F Rosa, et al.
Pageof 2